About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | HIV/AIDS Clinical Trials | 1,621 Studies Recruiting

Clinical TrialsHIV/AIDS

HIV/AIDS Clinical Trials

Browse 1,621 clinical trials for hiv/aids. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 101-120 of 1,621 trials

CompletedA Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-InfectionThis study will evaluate the efficacy and safety of glecaprevir/pibrentasvir (ABT-493/ABT-530) in non-cirrhotic chronic hepatitis C virus (HCV) genotype (GT)1 to GT6-infected…NCT03222583·Beijing, Beijing Municipality and 47 others

Related Searches

aidstrials human immunodeficiencytrials

Data from ClinicalTrials.govTerms

CompletedA Study to Assess The Relative Bioavailability of New Tablet Formulations of GSK1265744 in Healthy Adult SubjectsThis study will evaluate two new GSK1265744 sodium salt tablet formulations and provide data for selection of one of these tablet formulations for use in Phase 3.NCT02059031·Overland Park, Kansas

TerminatedHIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /RibavirinThe primary objective of this study is to evaluate the safety and efficacy of a Response Guided Therapy of boceprevir 800 mg dosed three times a day (TID) orally (PO) in…NCT01718301·Barcelona

CompletedAt-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsWe are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research.NCT01931644·Los Angeles, California

CompletedPilot Study of Adding Raltegravir (MK-0518) to Antiretroviral Therapy in Patients With Low Level ViremiaThe medicines used to treat HIV can suppress but cannot kill all the virus in the body. A small amount of virus remains at low levels in the part of the blood called the plasma.NCT00618371·Pittsburgh, Pennsylvania

CompletedOral Manifestations of Human Immunodeficiency Virus Infection in High Risk GroupsOBJECTIVES: I.NCT00004781

Enrolling by invitationEuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIVThe EuroSIDA study is a prospective observational cohort study of 23,000+ patients followed in 100+ clinics in 35 European countries, Israel and Argentina.NCT02699736·Buenos Aires and 109 others

CompletedDevelopment and Pilot Testing of a PHCI for Emergency Department Patients Who Decline Rapid HIV/ HCV ScreeningThe Centers for Disease Control and Prevention (CDC) recommends that emergency departments (EDs) and other health care facilities conduct HIV and HCV screening to identify and…NCT04137094·Providence, Rhode Island

CompletedReduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral TherapyA randomised controlled trial to investigate three methods to reduce early mortality in adults, adolescents and children aged 5 years or older starting antiretroviral therapy…NCT01825031·Eldoret and 7 others

CompletedA Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults Infected With Human Immunodeficiency Virus (HIV) (V114-018)This study is designed to 1) describe the safety, tolerability, and immunogenicity of V114 and Prevnar 13™ in pneumococcal vaccine-naïve adults infected with HIV and to 2)…NCT03480802·Orlando, Florida and 12 others

CompletedMother and Infant Visit Adherence and Treatment Engagement StudyThis is a 2x2 factorial cluster randomized trial of two interventions to improve retention and adherence for women and infants on Option B+.NCT02491177·Nairobi

CompletedA Clinical Research Study Designed To Determine If Treatment of Hepatitis C With Milk Thistle is More Effective Than No Treatment In Patients Infected With Both HIV And Hepatitis CThere is some information available that indicates that Milk Thistle is an effective treatment for liver disease.NCT00246363·New York, New York

CompletedSwitching Undetectables to SelzentryThis pilot single arm, single site, open-labeled switch study seeks to enroll thirty (30) HIV positive patients infected with CCR5 tropic virus that have achieved an undetectable…NCT01866267·Bellaire, Texas

CompletedA Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and LeukopeniaTo determine the maximum tolerated dose (MTD) and toxicity of sargramostim (recombinant granulocyte-macrophage colony-stimulating factor; GM-CSF) given by continuous intravenous…NCT00002009·Los Angeles, California and 1 other

CompletedStudy to Assess the Acceptability of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed-Dose Combination (FDC) Tablets in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Pediatric Participants, Using Matching Placebo TabletsThe primary purpose of this study is to assess the ability to swallow the scored film-coated darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) fixed-dose…NCT04006704·Phoenix, Arizona and 7 others

CompletedGW640385 Plus Ritonavir And NRTIs For 48 Weeks In HIV-1 Infected AdultsThis is a proof of concept (POC) single arm study of GW640385, a protease inhibitor, in combination with RTV and 2 or more nucleoside reverse transcriptase inhibitors (NRTI)…NCT00257621·Phoenix, Arizona and 8 others

CompletedThe Effect of an Enhanced Rice Bran Nutritional Supplement in HIVThe purpose of this study is to investigate the effects of the nutritional supplement rice bran arabinoxylan compound (RBAC) on metabolic syndrome variables in persons living with…NCT02214173·Miami, Florida

UnknownImpacts of Different ART Regimens on Lipid Metabolism in People Living With HIVTo compare the dynamic changes of lipid metabolism of people living HIV who treated with different antiretroviral therapy (ART) regimens such as Biktarvy EVG/c/TAF/FTC…NCT06019273·Hangzhou, Zhejiang

CompletedEfficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected PatientsThe purpose of this pilot study is to evaluate efficacy and safety of addition of IL-2 to pegylated interferon alpha 2a and ribavirin in HIV-HCV coinfected patients non-responders…NCT00196586·Paris

CompletedPharmacokinetics of Islatravir in Participants With Severe Renal Impairment (MK-8591-026)This study will evaluate the general tolerability and pharmacokinetics (PK) of a single 60 mg dose of MK-8591 (Islatravir) in participants with severe renal insufficiency…NCT04303156·Miami, Florida and 1 other

PreviousPage 6 of 82Next